Though prescription drug use has declined, Medicaid spending on pharmaceuticals has elevated not too long ago report exhibits.

The KFF report was based mostly on drug utilization knowledge from 2016 by 2022, in addition to CMS-64 Monetary Administration Experiences from fiscal yr 2017 by fiscal yr 2022. It comes as states are increasing the availability part out steady enrollment necessities, which prevented states from disenrolling Medicaid enrollees throughout the Covid-19 public well being emergency. Because of continued enrollment, Medicaid and CHIP enrollment reached historic highs, peaking at 94.5 million folks in April. This represents a rise of 23.1 million folks in comparison with 2020.

However regardless of progress in Medicaid enrollment, Medicaid prescription drug use by fiscal yr 2022 was under fiscal yr 2017 ranges, the researchers discovered. In 2017, there have been 765.6 million prescriptions. In 2020, the variety of prescriptions fell to 716.9 million. Subsequently, the variety of prescriptions elevated to 761.1 million in 2022 (however nonetheless lower than in 2017). In 2017, there have been 11.4 prescriptions per enrolled particular person, in comparison with 10.8 prescriptions per enrolled particular person in 2020 and 9.4 prescriptions per enrolled particular person in 2022. This proves that there are “decrease remedy use amongst these enrolled throughout the steady enrollment facility.”

Regardless of the decline in prescription drug use, web spending (spending after rebates) on Medicaid pharmaceuticals is estimated to have elevated from $29.8 billion in 2017 to $43.8 billion in 2022. This quantities to a rise of 47%. Web spending per prescription elevated from $39 in 2017 to $58 in 2022. Gross Medicaid spending (spending earlier than rebates) on outpatient pharmaceuticals additionally elevated from $64.7 billion in 2017 to $92.3 billion in 2022.

The rise in Medicaid drug spending is probably going on account of elevated spending on costly brand-name medication, KFF famous.

“Research have discovered substantial medication worth will increase increased than the inflation fee of latest years, but additionally rising launch costs for brand spanking new medicines,” the report stated.

What ought to healthcare actors take note of sooner or later? Hundreds of thousands of persons are anticipated to lose Medicaid protection as states part out steady enrollment provisions. This might “have an effect on future developments in drug use, relying on the extent to which enrollment declines and the way the well being wants of those that stay in this system change. Whereas nationwide utilization developments could stay comparatively secure, as they’ve lately, the lack of Medicaid protection on the particular person degree might have critical penalties for individuals who depend on common entry to pharmaceuticals,” KFF stated.

The researchers added that there have been efforts at each the state and federal ranges to cut back prescription drug prices, such because the Inflation Discount Act and proposed laws that goals to handle the practices of pharmacy profit managers (PBMs). All states have additionally handed at the least one regulation focusing on PPE, KFF famous.

Photograph: cagkansayin, Getty Photos